Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event, Product storage error
Clinical narrative: Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date; No adverse event; Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 061f22a) for COVID-19 prophylaxis.     No Medical History information was reported.    On 30-Nov-2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date), PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in the fridge on 11-Oct-2022 and administered to the patient on 30-Nov-2022, after 30-days use by date).    No concomitant medications were reported.  It was the individual vial with size of 2.5 mL and vial did not underwent the temperature excursion.  No treatment medications were reported.  This case is for the 8th patient of 8 adult patients described by the reported.   This case was linked to MODERNATX, INC.-MOD-2022-680810, MODERNATX, INC.-MOD-2022-680811, MODERNATX, INC.-MOD-2022-680808 (E2B Linked Report).; Sender's Comments: MODERNATX, INC.-MOD-2022-680810:Samer Reporter MODERNATX, INC.-MOD-2022-680808:Samer Reporter MODERNATX, INC.-MOD-2022-680811:Samer Reporter.